Latest Breaking News On - Diana harbort - Page 1 : vimarsana.com

Cosmo announces submission of Winlevi® to the European Medicines Agency (EMA)

Cosmo Pharmaceuticals N.V. / Key word(s): Regulatory Admission Cosmo announces submission of Winlevi® to .

Hikma And Cosmo Partner On Exclusive Licensing Agreement For Winlevi® (Clascoterone) For The Middle East And North Africa

Cosmo and Hikma Sign License Agreement for Winlevi® in 17 Middle Eastern and North African Countries

Cosmo Pharmaceuticals N.V. / Key word: Agreement Cosmo and Hikma Sign License Agreement for Winlevi® in 17 Middle Eastern and North African Countries.

Cosmo announces the beginning of the phase III trials in males for the treatment of androgenetic alo

Cosmo Pharmaceuticals N.V. / Key word(s): StudyCosmo announces the beginning of the phase III trials in males for the treatment of androgenetic alopecia 29.06.2023 / 06:15 GMT/BSTDublin, Ireland – June 29, 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced the beginning of the phase I.

Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea

Cosmo Pharmaceuticals N.V. / Key word(s): Agreement Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea 22.06.2023 / 06:15 GMT/BST Dublin, Ireland & Seoul, Korea – 22 .